Torsten B Meissner, Ph.D.
Title Assistant Professor of Surgery Institution Beth Israel Deaconess Medical Center Address Beth Israel Deaconess Medical Center Cls 11090 330 Brookline Ave Boston MA 02215
|
|
Overview
Torsten Meissner, PhD is an Assistant Professor of Surgery at Harvard Medical School with an appointment in the Division of Surgical Sciences at Beth Israel Deaconess Medical Center (BIDMC). The primary goal of his research is to create 'universal donor stem cells' that will resist immune rejection. Designed as 'off-the-shelf' products, ready for transplantation into any patient in need, such cells will be crucial to drive down the cost of production and thus democratize access to emerging cell therapies for indications such as type 1 diabetes (T1D), Parkinson's disease (PD), or macular degeneration (MD), where a particular cell type is lost over time and necessitates replacement with healthy tissue (StemJournal 2020; 2(1):1-5). Due to the paucity of donor material, stem cell-derived therapeutics grown in the laboratory are a promising alternative. A roadblock to these exciting new forms of treatment is immune rejection of the transplanted cells (Current Stem Cell Reports 2022; 8(4):206-218). During his postdoctoral work at the Harvard Stem Cell Institute Dr. Meissner has applied cutting-edge genome editing techniques to modify human pluripotent stem cell lines in order to protect them from immune rejection (PNAS 2019; 116:10441-10446). He has more than 15 years of experience in immunology, human pluripotent stem cell culture, cell differentiation, and genome editing. In 2019, Dr. Meissner joined the faculty of the Department of Surgery at BIDMC. In collaboration with the laboratory of Dr. Elliot Chaikof, MD PhD, he is developing hypoimmunogenic blood vessels from stem cell-derived building blocks that can be used as living 'off-the-shelf' products for vascular reconstruction.
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R01EB032824
(MEISSNER TORSTEN B)
Aug 5, 2022 - Apr 30, 2026
Immunoevasive Engineered Living Blood Vessels
Role: Co-Principal Investigator
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.